MBBChir, MA Cantab, MRCP
Ravindhi Murphy is an Academic Clinical Fellow in medical oncology and has advised Arterial since launch.
She is a graduate of Corpus Christi, College, Cambridge, with many years of clinical, analytical and research experience within the medical sector. She has led a variety of clinical audits, published original research and has spoken at numerous events both in the UK and overseas. Ravindhi brings to Arterial a broad knowledge of contemporary oncology and diabetes research in the UK, Australia and New Zealand.
Ravindhi is a member of the Royal College of Physicians and the American Society of Clinical Oncology. In 2007 she was awarded the coveted national research elective prize from Cancer Research UK and in 2015 was elected to the Board of Trustees for The Institute of Cancer Research.
She has previously worked in Melbourne, Australia, as part of the pioneering Tumour Vaccine Research Group at the Ludwig Institute for Cancer Research. She was then selected to hold an NIHR fellowship working on projects relating to pancreatic and hepatocellular carcinoma, at the Cancer Research UK clinical trials unit. In 2012 she has was awarded significant funding from Cancer Research UK to undertake projects on breast cancer genetics and Next-Generation sequencing.
She currently holds a Wellcome Trust funded clinical fellowship in drug discovery at the Institute of Cancer Research. She is completing her research under the supervision of Professor Paul Workman within the drug discovery unit at the Royal Marsden Hospital.